INDICATIONS
For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and
associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated
Glycosaminoglycan in horses. Studies have not been conducted to establish safety in breeding horses.
WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all
medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order
of a licensed veterinarian.
Please see Full Prescribing Information at www.adequan.com.
Adequan
®
and the Horse Head design are registered trademarks of Luitpold Pharmaceuticals, Inc.
© Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2017. PP-AI-US-0057 7/2017
There is
NO GENERIC ADEQUAN
®
The ONLY FDA approved equine PSGAG for the intramuscular treatment of non-infectious
degenerative joint disease (DJD) of the carpal and hock joints proven to:
• DIMINISH the destructive processes of degenerative joint disease
• REVERSE the processes which result in the loss of cartilage components
• IMPROVE overall joint function and associated lameness
Available for order! For more information about equine joint health and treatment with
Adequan
®
i.m., please visit www.adequan.com.